DELIVERY ORDER
Active75F40126F19003
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$3M
obligated · signed 2 months ago
NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY
Performance timeline
Start
Sep 14, 2026
End
Sep 13, 2030
with all options
Loading status
Estimated start: Sep 13, 2029
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Contract 75F40126F19003
UEI
MBT9RXJJ7428
Parent Company
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$3,017,553
Base + Exercised Options
$3,017,553
Total Ceiling Value
$3,017,553
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40123D00039
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.